|
Tuesday, March 23 — 8:00 AM — Salon 1 & Balconies
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section B - Hematopathology
Chaired By: Attilio Orazi and Sa Wang
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Low-Level Expression of a JAK2 Splice Variant with Exon 14 Deletion Is Common in Patients with Chronic Myeloproliferative Neoplasms
(1477)
Z Zhang, W Ma, TS Lee, X Zhang, X Wang, CH Yeh, M Albitar. - Quest Diagnostics Nichols Institute, San Juan Capistrano, CA; University of Minnesota, Minneapolis, MN.
|  Add |
| 8:15 |
Detection of KIT D816V Mutation in the Peripheral Blood of Patients with Systemic Mastocytosis Correlates with the Involvement of Multiple Hematopoietic Cell Lineages and Disease Severity
(1441)
O Simakova, TM Wilson, D Maric, W Fu, J Woelfel, P Noel, DD Metcalfe, I Maric. - NIH, Bethesda, MD.
| Add |
| 8:30 |
Systemic Mastocytosis with Associated Clonal Hematological Non-Mast Cell Lineage Disorder (SM-AHNMD) Shows Distinct Hematologic Features and Reveals a Common Clonal Origin of Myeloid and Mast Cells
(1392)
RN Miranda, G Tang, DM Jones, YO Huh, LJ Medeiros, SA Wang. - M.D. Anderson Cancer Center, Houston, TX; University of Massachusetts, Worcester, MA.
| Add |
| 8:45 |
Idiopathic Cytopenia of Undetermined Significance (ICUS): the Importance of Clinical, Morphologic and Cytogenetic (CG) Correlation
(1343)
CA Hanson, DK Durnick, JD Hoyer, JM Hodnefield, RP Ketterling, DP Steensma. - Mayo Clinic, Rochester, MN.
| Add |
| 9:00 |
Myelodysplasia and Bone Marrow failure in an autosomal dominant monocytopenia Immunodeficiency Syndrome
(1294)
KR Calvo, DC Vinh, I Maric, P Noel, M Stetler-Stevenson, D Arthur, S Pittaluga, SM Holland. - NIH Clinical Center, Bethesda, MD; NIAID, NIH, Bethesda, MD; NCI, NIH, Bethesda, MD.
| Add |
| 9:15 |
Wilms' Tumor Gene 1 (WT1) Protein Expression Pattern Is Associated with Adverse Clinical Outcome Among Pre-B-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL) Patients (pts)
(1384)
A Mansoor, M Akbari, A Akbari, A Surmawala, E Torlakovic, I Mirza. - University of Calgary/CLS, Calgary, AB, Canada; Lion's Gate Hospital, Vancouver, BC, Canada; University of Alberta, Edmonton, AB, Canada; University of Saskatchewan, Saskatoon, SK, Canada.
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
| |
| 11:00 |
T-Cell-Associated Fluorescence In Situ Hybridization (FISH) Probes May Help Distinguish between T Lymphoblastic Leukemia (T-LBL) and Acute Myeloid Leukemia with T-cell Antigen Expression (AML-T)
(1287)
DS Bosler, CA Hanson, RA Knudson, RP Ketterling, JD Hoyer. - Cleveland Clinic, Cleveland, OH; Mayo Clinic, Rochester, MN.
| Add |
| 11:15 |
Mechanisms of Chemotherapy-Resistance in Elderly AML Patients: An Immunohistochemical and Molecular Study with therapeutic and Prognostic implications
(1292)
JT Bunning, HM Kantarjian, LJ Medeiros, M Nguyen, S Konoplev, C Bueso-Ramos. - MD Anderson Cancer Center, Houston, TX.
| Add |
| 11:30 |
Acute Myeloid Leukemia (AML) with Monosomal Karyotype Is Characterized by Absence of NPM1 and FLT3 Mutations, Worse Clinical Outcome and Usually Falls within AML with Myelodysplasia-Related Changes (MRC)
(1463)
OK Weinberg, M Seetharam, L Ren, L Ma, K Seo, J Zehnder, J Gotlib, DA Arber. - Stanford University Medical Center, Stanford, CA.
| Add |
| 11:45 |
Day 14 Bone Marrow Stromal Microenvironment Independently Predicts Long Term Survival in Acute Myelogeneous Leukemia (AML)
(1312)
R Dewar, R Kalluri. - Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA; Harvard-MIT, Boston, MA.
| Add |
|
|
